Boston Scientific Aktie
WKN: 884113 / ISIN: US1011371077
|
24.07.2024 12:32:51
|
Boston Scientific Corp Q2 Profit Increases, Beats Estimates
(RTTNews) - Boston Scientific Corp (BSX) reported earnings for its second quarter that increased from last year and beat the Street estimates.
The company's earnings came in at $324 million, or $0.22 per share. This compares with $261 million, or $0.18 per share, in last year's second quarter.
Excluding items, Boston Scientific Corp reported adjusted earnings of $914 million or $0.62 per share for the period.
Analysts on average had expected the company to earn $0.58 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 14.4% to $4.12 billion from $3.60 billion last year.
Boston Scientific Corp earnings at a glance (GAAP) :
-Earnings (Q2): $324 Mln. vs. $261 Mln. last year. -EPS (Q2): $0.22 vs. $0.18 last year. -Revenue (Q2): $4.12 Bln vs. $3.60 Bln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Boston Scientific Corp.mehr Nachrichten
Analysen zu Boston Scientific Corp.mehr Analysen
Aktien in diesem Artikel
| Boston Scientific Corp. | 82,00 | 0,49% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.